Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 3;12:604229. doi: 10.3389/fgene.2021.604229

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Chen, Wang, Cho, Zhou and Zhang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Prognostic value of the identified signature was evaluated in rectal cancer from the TCGA-READ (A–D), GSE87211 (E–H), GSE119409 (I), and GSE150082 (J) datasets. (A,E) Overall survival analysis between low- and high- risk groups stratified by the risk score. (B,F) The receiver operating characteristic (ROC) curve was used to evaluate the predictive efficiency of the overall survival rate. (C,G) Relapse free survival analysis between low- and high- risk groups stratified by the risk score. (D,H) The ROC curve was used to evaluate the predictive efficiency of relapse free survival rate. (I) The distribution of risk score in rectal cancer patients stratified by the response to neoadjuvant radiotherapy (unpaired T-tests). (J) The distribution of risk score in locally advanced rectal cancer patients tratified by the response to chemoradiotherapy (unpaired T-tests). *P < 0.05.